Aadi Bioscience, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Aadi Bioscience, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • Aadi Bioscience, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 25.5 %, a 53.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 25.5 +8.92 +53.8% Sep 30, 2024
Q2 2024 23.5 +7.7 +48.9% Jun 30, 2024
Q1 2024 20 +3.62 +22.1% Mar 31, 2024
Q4 2023 18.6 +2.83 +17.9% Dec 31, 2023
Q3 2023 16.6 +0.96 +6.15% Sep 30, 2023
Q2 2023 15.8 +0.98 +6.63% Jun 30, 2023
Q1 2023 16.4 +1.3 +8.61% Mar 31, 2023
Q4 2022 15.8 -1.7 -9.73% Dec 31, 2022
Q3 2022 15.6 -37.2 -70.4% Sep 30, 2022
Q2 2022 14.8 +69.1 Jun 30, 2022
Q1 2022 15.1 +72.1 Mar 31, 2022
Q4 2021 17.5 +80.4 Dec 31, 2021
Q3 2021 52.8 +72.5 Sep 30, 2021
Q2 2021 -54.3 -556 -111% Jun 30, 2021
Q1 2021 -57 -78 -372% Mar 31, 2021
Q4 2020 -62.9 -74.8 -628% Dec 31, 2020
Q3 2020 -19.7 -28.5 -322% Sep 30, 2020
Q2 2020 502 Jun 30, 2020
Q1 2020 21 Mar 31, 2020
Q4 2019 11.9 Dec 31, 2019
Q3 2019 8.86 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.